Your browser doesn't support javascript.
loading
Eruptive keratoacanthomas secondary to nivolumab immunotherapy.
Bednarek, Robert; Marks, Katherine; Lin, George.
Affiliation
  • Bednarek R; Department of Dermatology, Geisinger Medical Center, Danville, PA, USA.
  • Marks K; Department of Dermatology, Geisinger Medical Center, Danville, PA, USA.
  • Lin G; Department of Pathology, Division of Dermatopathology, Geisinger Medical Center, Danville, PA, USA.
Int J Dermatol ; 57(3): e28-e29, 2018 03.
Article in En | MEDLINE | ID: mdl-29318617
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / Antineoplastic Agents, Immunological / Nivolumab / Keratoacanthoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Int J Dermatol Year: 2018 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / Antineoplastic Agents, Immunological / Nivolumab / Keratoacanthoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Int J Dermatol Year: 2018 Document type: Article Affiliation country: Estados Unidos